Thanks for the responses. I'll look into all of them.
On mine, I think $ABOS continues to strengthen as they get through Phase II with subsequent data potentially causing explosive growth. They are well capitalized.
$PMN is my favorite AD therapeutic (based on the scientific data), but the company still needs to raise their Phase 2 capital which will cause dilution
$KLGDF has a miniscule market cap and a lot of promising property. But no major hits yet. If they do though, it will go crazy. They'll need to finance of course.